İlker KILIÇCIOĞLU, Nuray VAROL, Ece KONAC, Yusuf KIZIL, Alper DİLCİ, Sabri USLU, Utku AYDİL

Expression profiles of CD11b, galectin-1, beclin-1, and caspase-3 in nasal polyposis

Background/aim: Nasal polyposis is a chronic inflammatory disease affecting the paranasal sinuses and nasal mucosae. It is thought that genetic and molecular mechanisms in inflammatory and apoptotic pathways are the main factors in the etiopathogenesis of nasal polyposis. The aim of this study was to investigate the expression patterns of CD11b, galectin-1, beclin-1, and caspase-3 in nasal polyps. Materials and methods: The mRNA expression levels of CD11b, galectin-1, beclin-1, and caspase-3 protein and western blot analysis of caspase-3 protein were evaluated in inferior turbinate mucosae and nasal polyp tissues. Results: CD11b expression was markedly higher in nasal polyp tissues when compared to turbinate mucosae (5.5 times higher, P < 0.05). Expression of galectin-1 was not statistically higher in nasal polyp tissues when compared to the controls. Beclin-1 expression in nasal polyp tissues was lower than in controls (17 times lower, P < 0.05). Caspase-3 expression was significantly lower in nasal polyp tissues than in controls (5.5 times lower, P < 0.05). Conclusion: Inflammation, apoptosis, and hyperproliferation are the major cellular processes in nasal polyposis and these proteins may take part and play some important roles in formation of this disease and the targeting of new treatment protocols.

PDF

___

1. Hao J, Pang YT, Wang DY. Diffuse mucosal inflammation in nasal polyps and adjacent middle turbinate. Otolaryngol Head Neck Surg 2006; 134: 267-275.
2. Bernstein JM. Update on the molecular biology of nasal polyposis. Otolaryngol Clin North Am 2005; 38: 1243-1255.
3. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol 2000; 14: 279-290.
4. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003; 3: 1-6.
5. Cho SH, Lee SH, Kim KR, Lee HM, Lee SH, Kim TH. Expression and distributional patterns of the inhibitor of apoptosis protein family and caspase 3 in nasal polyps. Arch Otolaryngol Head Neck Surg 2008; 134: 316-321.
6. Bateman ND, Fahy C, Woolford TJ. Nasal polyps: still more questions than answers. J Laryngol Otol 2003; 117: 1-9.
7. Solovjov DA, Pluskota E, Plow EF. Distinct roles for the alpha and beta subunits in the functions of integrin αMβ2. J Biol Chem 2005; 280: 1336-1345.
8. Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, Lee AT, Chung SA, Ferreira RC, Pant PV et al. Association of systemic lupus erythematosus with C8orf13- BLK an ITGAM-ITGAX. N Engl J Med 2008; 358: 900-909.
9. Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 2001; 20: 7486-7493.
10. Takacs-Vellai K, Vellai T, Puoti A, Passannante M, Wicky C, Streit A, Kovacs AL, Müller F. Inactivation of the autophagy gene bec-1 triggers apoptotic cell death in C. elegans. Curr Biol 2005; 15: 1513-1517.
11. Grütter MG. Caspases: key players in programmed cell death. Curr Opin Struct Biol 2000; 10: 649-655.
12. Konac E, Varol N, Yilmaz A, Menevse S, Sozen S. DNA methyltransferase inhibitor-mediated apoptosis in the Wnt/β- catenin signal pathway in a renal cell carcinoma cell line. Exp Biol Med 2013; 238: 1009-1016.
13. Varol N, Konac E, Bilen CY. Does Wnt/β-catenin pathway contribute to the stability of DNMT1 expression in urological cancer cell lines? Exp Biol Med 2015; 240: 624-630.
14. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 2002; 30: e36.
15. Larsen PL, Tos M, Kujipers W, van der Beek JMH. The early stages of polyp formation. Laryngoscope 1992; 102: 670-677.
16. Foresi A, Teodoro C, Leone C, Pelucchi A, DIppolito R, Chetta A, Olivieri D. Eosinophil apoptosis in induced sputum from patients with seasonal allergic rhinitis and with asymptomatic and symptomatic asthma. Ann Allergy Asthma Immunol 2000; 84: 411-416.
17. Wooley KL, Gibson PG, Carty K, Wilson AJ, Twaddell SH, Wooley MJ. Eosinophil apoptosis and the resolution of airway inflammation in asthma. Am J Resp Crit Care Med 1996; 154: 237-243.
18. Lim LH, Flower RJ, Perretti M, Das AM. Glucocorticoid receptor activation reduces CD11b and CD49d levels on murine eosinophils: characterization and functional relevance. Am J Respir Cell Mol Biol 2000; 22: 693-701.
19. Spoelstra FM, Hovenga H, Noordhoek JA, Postma DS, Kaufmann HF. Changes in CD11b and L-selectin expression on eosinophils are mediated by human lung fibroblasts in vitro. Am J Respir Crit Care Med 1998; 158: 769-777.
20. Cavallari FE, Valera FC, Gallego AJ, Malinsky RR, Küpper DS, Milanezi C, Silva JS, Tamashiro E, Anselmo-Lima WT. Expression of RANTES, eotaxin-2, ICAM-1, LFA-1 and CCR3 in chronic rhinosinusitis patients with nasal polyposis. Acta Cir Bras 2012; 27: 645-649.
21. Walker C, Rihs S, Braun RK, Betz S, Bruijnzeel P. Increased expression of CD11b and functional changes in eosinophils after migration across endothelial cell monolayers. J Immunol 1993; 150: 4061-4071.
22. Yang RY, Rabinovich GA, Liu FT. Galectins: structure, function and therapeutic potential. Expert Rev Mol Med 2008; 13: 17.
23. Delorge S, Saussez S, Pelc P, Devroede B, Marchant H, Burchert M, Zeng FY, Danguy A, Salmon I, Gabius HJ et al. Correlation of galectin-3/galectin-3-binding sites with low differentiation status in head and neck squamous cell carcinomas. Otolaryngol Head Neck Surg 2000; 122: 834-841.
24. Park WS, Jung WK, Park SK, Heo KW, Kang MS, Choi YH, Kim GY, Park SG, Seo SK, Yea SS et al. Expression of galectin-9 by IFN-γ stimulated human nasal polyp fibroblasts through MAPK, PI3K, and JAK/STAT signaling pathways. Biochem Biophys Res Commun 2011; 411: 259-264.
25. Delbrouck C, Gabius HJ, Kaltner H, Decaestecker C, Kiss R, Hassid S. Expression patterns of galectin-1 and galectin-3 in nasal polyps and middle and inferior turbinates in relation to growth regulation an immunosupression. Arch Otolaryngol Head Neck Surg 2003; 129: 665-669.
26. Delbrouck C, Doyen I, Belot N, Decaestecker C, Ghanooni R, de Lavareille A, Kaltner H, Choufani G, Danguy A, Vandenhoven G et al. Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration. Lab Invest 2002; 82: 147-158.
27. Devouassoux G, Pachot A, Laforest L, Diasparra J, Freymond N, Van Gasse E, Mougin B, Pacheco Y. Galectin-10 mRNA is overexpressed in peripheral blood of aspirin-induced asthma. Allergy 2008; 63: 125-131.
28. Alles A, Alley K, Barrett JC, Buttyan R, Columbano A, Cope FO, Copelan EA, Duke RC, Farel PB, Gershenson LE et al. Apoptosis: a general comment. FASEB J 1991; 5: 2127-2128.
29. Küpper DS, Valera FC, Malinsky R, Milanezi CM, Silva JS, Tamashiro E, Anselmo-Lima WT. Expression of apoptosis mediators p53 and caspase 3, 7, and 9 in chronic rhinosinusitis with nasal polyposis. Am J Rhinol Allergy 2014; 28: 187-191.
30. Cho HW, Park SK, Heo KW, Hur DY. Methotrexate induces apoptosis in nasal polyps via caspase cascades and both mitochondria-mediated and p38 mitogen-activated protein kinases/Jun N-terminal kinase pathways. Am J Rhinol Allergy 2013; 27: 26-31.
31. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672-676.
32. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, Mannucci S, De Nisi MC, Toscano M, Malagnino V et al. Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 2007; 30: 429-436.
33. Shen Y, Li DD, Wang LL, Deng R, Zhu XF. Decreased expression of autophagy-related proteins in malignant epithelial ovarian cancer. Autophagy 2008; 4: 1067-1068.
34. Ahn CH, Jeong EG, Lee JW, Kim MS, Kim SH, Kim SS, Yoo NJ, Lee SH. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS 2007; 115: 1344-1349.
35. Hirano S, Asano K, Namba M, Kanai K, Hisamitsu T, Suzaki H. Induction of apoptosis in nasal polyp fibroblasts by glucocorticoids in vitro. Acta Otolaryngol 2003; 123: 1075- 1079.
36. Nakada H, Kase Y, Matsunaga T, Komoda T, Iinuma T. Caspase 3 activation in nasal capillary in patients with epistaxis. Otolaryngol Head Neck Surg 2003; 128: 632-639.
37. Cho SH, Lee SH, Kim KR, Lee HM, Lee SH, Kim TH. Expression and distributional patterns of the inhibitor of apoptosis protein family and caspase 3 in nasal polyps. Arch Otolaryngol Head Neck Surg 2008; 134: 316-321.
38. Lin H, Lin D, Xiong X. Differential expression of livin, caspase-3, and second mitochondria-derived activator of caspases in chronic rhinosinusitis with nasal polyps. Otolaryngol Head Neck Surg 2014; 151: 1067-1072.
39. Hasui K, Nagai T, Wang J, Jia X, Aozasa K, Izumo S. Immunohistochemistry of programmed cell death in archival human pathology specimens. Cells 2012; 1: 74-88.
40. Pezato R, Voegels RL, Stamm AC, Gregorio LC. Why we should avoid using inferior turbinate tissue as control to nasal polyposis studies. Acta Otolaryngol 2016; 136: 973-975.